Type 2 Diabetes in Older People; The Importance of Blood Pressure Control

被引：9

作者：

Jindal A. ^{[1
]}

Whaley-Connell A. ^{[2
,3
,4
]}

Sowers J.R. ^{[5
,6
]}

机构：

[1] Department of Internal Medicine, Division of Hospital Medicine, School of Medicine, Univeristy of Missouri, Columbia, MO, 65212, One Hospital Drive

[2] Department of Internal Medicine, Harry S Truman Memorial Veterans Hospital, School of Medicine, University of Missouri, Columbia, MO, 65212, One Hospital Drive

[3] Department of Nephrology and Hypertension, Harry S Truman Memorial Veterans Hospital, School of Medicine, University of Missouri, Columbia, MO, 65212, One Hospital Drive

[4] Department of Endocrinology and Metabolism, Harry S Truman Memorial Veterans Hospital, School of Medicine, University of Missouri, Columbia, MO, 65212, One Hospital Drive

[5] Department of Internal Medicine, Harry S Truman Memorial Veterans Hospital, School of Medicine, University of Missouri, Columbia, MO, 65212, D109 Diabetes Center HSC, One Hospital Drive

[6] Department of Endocrinology and Metabolism, Harry S Truman Memorial Veterans Hospital, School of Medicine, University of Missouri, Columbia, MO, 65212, D109 Diabetes Center HSC, One Hospital Drive

来源：

Current Cardiovascular Risk Reports | 2013年 / 7卷 / 3期

基金：

美国国家卫生研究院;

关键词：

Blood pressure control; Diabetes; Diabetes complications; Hypertension;

D O I：

10.1007/s12170-013-0301-5

中图分类号：

学科分类号：

摘要：

Diabetes and hypertension often coexist and their coexistence substantially promotes cardiovascular disease (CVD) and chronic kidney disease. Control of blood pressure to a level of 140/90 mmHg in people with diabetes can prevent or at least delay CVD and chronic kidney disease. In the past many society treatment guidelines have stressed tight blood pressure control (=<130/80) for people with diabetes. But recommendations for such tight blood pressure control have not been supported by recent large randomized control trials, especially in in elderly. Here we review the recent literature regarding the benefits of blood pressure control in elderly patients with diabetes. We further focus on evidence for specific levels of blood pressure treatment goals, in this population subset. © 2013 Springer Science+Business Media New York.

引用

页码：233 / 237

页数：4

共 27 条

[21]

Uzu T., Kida Y., Shirahashi N., Harada T., Yamauchi A., Nomura M., Et al., Cerebral microvascular disease predicts renal failure in type 2 diabetes, J Am Soc Nephrol, 21, 3, pp. 520-526, (2010)

[22]

Hsieh M.C., Hsieh Y.T., Cho T.J., Chen J.F., Lin S.D., Chen H.C., Et al., Remission of diabetic nephropathy in type 2 diabetic asian population: role of tight glucose and blood pressure control, Eur J Clin Invest., 41, 8, pp. 870-878, (2011)

[23]

Uzu T., Kida Y., Yamauchi A., Kume S., Isshiki K., Araki S., Et al., The effects of blood pressure control levels on the renoprotection of type 2 diabetic patients without overt proteinuria, J Am Soc Hypertens, 6, 2, pp. 124-131, (2012)

[24]

Gaede P., Tarnow L., Vedel P., Parving H.H., Pedersen O., Remission to normoalbuminuria during multifactorial treatment preserves kidney function in patients with type 2 diabetes and microalbuminuria, Nephrol Dial Transplant, 19, 11, pp. 2784-2788, (2004)

[25]

de Galan B.E., Perkovic V., Ninomiya T., Pillai A., Patel A., Cass A., Et al., Lowering blood pressure reduces renal events in type 2 diabetes, J Am Soc Nephrol, 20, 4, pp. 883-892, (2009)

[26]

Reboldi G., Gentile G., Angeli F., Ambrosio G., Mancia G., Verdecchia P., Effects of intensive blood pressure reduction on myocardial infarction and stroke in diabetes: a meta-analysis in 73,913 patients, J Hypertens, 29, 7, pp. 1253-1269, (2011)

[27]

Lewington S., Clarke R., Qizilbash N., Peto R., Collins R., Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies, Lancet, 360, 9349, pp. 1903-1913, (2002)

← 1 2 3 →